
Rare Earth Demonstration Plant Update Following Comprehensive Review
The data gathered from the operation of the Demonstration Plant will be critical in advancing the design and economics of a commercial plant utilizing the Company's proprietary processing and separation technology. Once operational, the Demonstration Plant is planned to operate for up to 10 months and produce up to 10 tons of separated neodymium/praseodymium (Nd/Pr) oxide.
Ken Mushinski, the Company's President and Chief Executive Officer stated, 'As we focused the prior weeks on the full system connectivity and materials of construction, we are pleased to report that our team has now completed the updated Piping and Instrumentation Diagrams and are sourcing the necessary additional equipment and construction materials. Further, we have begun updating our system control narratives to align with the upgraded design.' Mr. Mushinski added, 'We believe our innovative technology, along with our world-class Bear Lodge mineral deposit, can become a cornerstone of America's rare earth needs at a time when the U.S. government recognizes China's market dominance must be addressed.'
As the Company continues to advance its Demonstration Plant project, the Company is participating in the continuing national conversation focused on securing a reliable domestic supply of critical rare earths to meet the nation's defense and high-tech needs. On June 24, 2025, Mr. Mushinski was invited to testify at the U.S. House Committee on Small Business' hearing on critical minerals titled ' Securing America's Mineral Future: Unlocking the Economic Value Beneath Our Feet.' Reflecting on this experience, Mr. Mushinski commented, 'I was gratified to provide RER's perspective on a sustainable rare earth supply chain and encourage the federal government to support the establishment of a diversified source of rare earths to meet our domestic and allied partners' needs, such that the China market dominance will no longer control America's technology future.'
Rare Element Resources Ltd. is a publicly traded, strategic materials company focused on delivering rare earth products for technology, energy, and defense applications by advancing the Bear Lodge Rare Earth Project in northeast Wyoming incorporating the Company's proprietary rare earth processing and separation technology. Bear Lodge is a significant mineralized district containing many of the less common, more valuable, critical rare earths that are essential for high-strength permanent magnets, electronics, fiber optics, laser systems for medical technology and defense, as well as technologies like electric vehicles, solar panels, and wind turbines.
Forward-Looking Statements
This news release contains forward-looking statements and information within the meaning of securities legislation in the United States and Canada (collectively, 'forward-looking statements'). Except for statements of historical fact, certain information contained herein constitutes forward-looking statements. Forward-looking statements are usually identified by our use of certain terminology, including 'will,' 'believes,' 'may,' 'expects,' 'should,' 'seeks,' 'anticipates,' 'plans,' 'has potential to,' or 'intends' (including negative and grammatical variations thereof), or by discussions of strategy or intentions. Such forward-looking statements include statements regarding (i) expectations that the Demonstration Plant will generate the operational and economic data necessary for the design of a commercial-scale plant; (ii) the Company's ability to timely complete a design and equipment review at the Demonstration Plant, followed by implementation of upgrades and commence operations in the first quarter of 2026; (iii) anticipated delays and the expected timeline for shake-down activities and commencing operations of the Demonstration Plant in late 2025; (iv) the Company's ability to meet the demand for a secure and diversified domestic source of critical rare earths for U.S. defense and high-tech applications; and (v) expectations that the Demonstration Plant will operate for up to 10 months and produce up to 10 tons of Nd/Pr oxide, supporting discussions with potential strategic partners and offtake customers. Factors that could cause actual results to differ materially from those contemplated, expressed or implied by the forward-looking statements contained in this news release include, but are not limited to, the ability to operate the Demonstration Plant for a sufficient amount of time to ascertain commercialization decisions, the ability to maintain Demonstration Plant licensing and permits, the possible full impacts of inflation and supply chain issues, such as delays or further cost increases, tariffs or trade restrictions, and other matters discussed under the caption 'Risk Factors' in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and our other periodic and current reports filed with the U.S. Securities and Exchange Commission (the 'SEC') and available on www.sec.gov and with the Canadian securities commissions available on www.sedarplus.ca. There can be no assurance that future developments affecting the Company will be those anticipated by management. Please refer to the discussion of these and other uncertainties and risk factors set out in our filings made from time to time with the SEC and the Canadian regulators, including, without limitation, our reports on Form 10-K and Form 10-Q. Any forward-looking statement made by us in this news release is based only on information currently available to us and speaks only as of the date on which it is made. While we may elect to update our forward-looking statements at any time, we undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
28 minutes ago
- Business Wire
HCSG Reports Second Quarter Results
- Exceeds Growth Expectations Raises 2025 Cash Flow Forecast Announces $50.0MM Share Repurchase Plan Revenue of $458.5 million, an increase of 7.6% over the prior year. Net income and diluted EPS of ($32.4) million and ($0.44); includes $0.65 non-cash charge related to previously announced Genesis HealthCare restructuring. Cash flow from operations of $28.8 million; cash flow from operations (excluding the change in payroll accrual) of $8.5 million, an increase of $10.9 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to $85.0 million. Announces $50.0 million, 12-month share repurchase plan. BENSALEM, Pa.--(BUSINESS WIRE)--Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended June 30, 2025. Ted Wahl, Chief Executive Officer, stated, 'Second quarter growth exceeded our expectations. New client wins and higher retention drove our organic growth, and we have carried that positive momentum into the back half of the year. Despite the previously announced Genesis news and resulting impact on our Q2 reported results, our 2025 growth plans and cash flow outlook remain strong. We are confident that continuing to execute on our strategic priorities, supported by our strong business fundamentals, will enable us to further accelerate growth, while delivering sustainable, profitable results.' Second Quarter Results Revenue was reported at $458.5 million. Segment revenues for Environmental and Dietary Services were reported at $205.8 million and $252.7 million, respectively. The Company reiterated its expectation for 2025 mid-single digit revenue growth. Cost of services was reported at $455.5 million or 99.4% and includes the impact of the $61.2 million or 13.4% non-cash charge related to the previously announced Genesis restructuring. The Company's goal is to manage the second half of 2025 cost of services in the 86% range. SG&A was reported at $49.2 million; after adjusting for the $4.7 million increase in deferred compensation, actual SG&A was $44.5 million or 9.7%. The Company expects to manage SG&A in the 9.5% to 10.5% range in the near term, with the longer term goal of managing those costs into the 8.5% to 9.5% range. Segment margin for Environmental Services was reported at 0.8% and includes the impact of a $20.3 million or 9.9% non-cash charge related to the previously announced Genesis restructuring. Segment margin for Dietary Services was reported at (10.1%), and includes the impact of a $40.9 million or 16.2% non-cash charge related to the previously announced Genesis restructuring. Net income and diluted EPS were reported at ($32.4) million and ($0.44), respectively, and includes the impact of the $0.65 non-cash charge (or $61.2 million pretax, tax effected at 22.7%) related to the previously announced Genesis restructuring. As previously announced, the Company estimates a third quarter $0.04 per share non-cash charge related to the Genesis restructuring. Cash flow from operations was reported at $28.8 million; after adjusting for the $20.3 million increase in the payroll accrual, cash flow from operations was $8.5 million. The Company raised its 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to $85.0 million. Balance Sheet and Liquidity The Company's primary sources of liquidity are cash flow from operating activities, cash and cash equivalents, and its revolving credit facility. As of the end of the second quarter, the Company had cash and marketable securities of $164.1 million and a $500.0 million credit facility, inclusive of its $200.0 million accordion, which expires in November 2027. Share Repurchases The Company also announced that it plans to accelerate the pace of its share buybacks, and over the next 12 months, intends to repurchase $50.0 million shares of its common stock under its February 2023 share repurchase authorization. The Company repurchased $7.6 million of common stock during the second quarter. Year to date, the Company has repurchased $14.6 million of its common stock. Mr. Wahl stated, 'Over the course of the last several years, we have continuously strengthened our balance sheet and expect strong cash flow generation over the next 12 months and beyond. We have demonstrated a prudent and balanced approach to capital allocation, including first and foremost investing in our growth initiatives. The current valuation of our stock relative to our long-term growth potential offers a unique opportunity with the buyback to return significant capital to shareholders.' Conference Call and Upcoming Events The Company will host a conference call on Wednesday, July 23, 2025, at 8:30 a.m. Eastern Time to discuss its results for the three months ended June 30, 2025. The call may be accessed via phone at 1 (800) 715-9871, Conference ID: 9951274. The call will be simultaneously webcast under the 'Events & Presentations' section of the Investor Relations page on the Company's website, A replay of the webcast will also be available on the website for one year following the date of the earnings call. The Company will be attending and presenting at the Baird 2025 Global Healthcare Conference on September 10, 2025 at the InterContinental Barclay NY. About Healthcare Services Group, Inc. Healthcare Services Group (NASDAQ: HCSG) is a leader in managing housekeeping, laundry, dining, and nutritional services within the healthcare industry. With nearly 50 years of experience, HCSG aims to provide improved operational, regulatory, and financial outcomes for our clients. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as 'believes,' 'anticipates,' 'plans,' 'expects,' 'estimates,' 'will,' 'goal,' 'intend' and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers' compensation, general liability and auto insurance; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; the impacts of past or future cyber attacks or breaches; global events including ongoing international conflicts; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2024 under 'Government Regulation of Customers,' 'Service Agreements and Collections,' and 'Competition' and under Item 1A. 'Risk Factors' in such Form 10-K. These factors, in addition to delays in payments from customers and/or customers undergoing restructurings, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results have been in the past and could in the future be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) cannot be passed on to our customers. In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard. USE OF NON-GAAP FINANCIAL INFORMATION To supplement HCSG's consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America ('GAAP'), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies. The Company is presenting net cash flow from operations (excluding the impact of payroll accrual), earnings before interest, taxes, depreciation and amortization ('EBITDA') and EBITDA excluding items impacting comparability ('Adjusted EBITDA'). We cannot provide a reconciliation of forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP. HEALTHCARE SERVICES GROUP, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in thousands) June 30, 2025 December 31, 2024 Cash and cash equivalents $ 82,818 $ 56,776 Restricted cash equivalents 326 3,355 Marketable securities, at fair value 51,674 50,535 Restricted marketable securities, at fair value 29,258 25,105 Accounts receivable, net 292,210 330,907 Notes receivable — short-term, net 31,628 51,429 Other current assets 44,380 38,545 Total current assets 532,294 556,652 Property and equipment, net 28,215 28,198 Notes receivable — long-term, net 45,084 41,054 Goodwill 80,042 75,529 Other intangible assets, net 8,263 9,442 Deferred compensation funding 51,548 49,639 Other assets 56,754 42,258 Total assets $ 802,200 $ 802,772 Accrued insurance claims — current $ 24,578 $ 25,148 Other current liabilities 189,354 167,399 Total current liabilities 213,932 192,547 Accrued insurance claims — long-term 50,833 51,869 Deferred compensation liability — long-term 51,699 50,011 Lease liability — long-term 7,048 8,033 Other long-term liabilities 1,650 385 Stockholders' equity 477,038 499,927 Total liabilities and stockholders' equity $ 802,200 $ 802,772 Expand HEALTHCARE SERVICES GROUP, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES (Unaudited) For the Three Months Ended For the Six Months Ended June 30, June 30, 2025 2024 2025 2024 GAAP net (loss) income $ (32,366 ) $ (1,788 ) $ (15,138 ) $ 13,521 Income tax (benefit) provision (9,522 ) (198 ) (2,856 ) 5,807 Interest, net (1,976 ) 184 (4,186 ) 138 Depreciation and amortization (1) 5,001 3,679 8,879 7,210 EBITDA $ (38,863 ) $ 1,877 $ (13,301 ) $ 26,676 Share-based compensation 2,541 2,113 6,279 4,597 Adjusted EBITDA $ (36,322 ) $ 3,990 $ (7,022 ) $ 31,273 Adjusted EBITDA as a percentage of revenue (7.9 )% 0.9 % (0.8 )% 3.7 % Expand Reconciliation of GAAP cash flows provided by (used in) operations to net cash flows from operations (excluding the change in payroll accrual) For the Three Months Ended For the Six Months Ended June 30, June 30, 2025 2024 2025 2024 GAAP cash flows provided by (used in) operations $ 28,787 $ 16,319 $ 56,288 $ (9,714 ) Accrued payroll (2) (20,256 ) (18,677 ) (15,665 ) (1,862 ) Cash flows from operations (excluding the change in payroll accrual) $ 8,531 $ (2,358 ) $ 40,623 $ (11,576 ) Expand 1. Includes right-of-use asset depreciation of $2.1 million and $4.2 million for the three and six months ended June 30, 2025, and $1.9 million and $3.8 million for the three and six months ended June 30, 2024. 2. The accrued payroll adjustment reflects changes in accrued payroll for the three and six months ended June 30, 2025 and 2024. The Company processes payroll on set weekly and bi-weekly schedules, and the timing of payments may result in operating cash flow increases or decreases which are not indicative of the Company's quarterly cash flow performance. Expand Contacts Company Contacts: Theodore Wahl President and Chief Executive Officer Vikas Singh Executive Vice President and Chief Financial Officer Matthew J. McKee Chief Communications Officer 215-639-4274 investor-relations@ Industry: Retail Other Professional Services Health Consumer Other Health Professional Services Practice Management Managed Care General Health Hospitals Other Consumer Fitness & Nutrition Food/Beverage Nursing Get RSS Feed Healthcare Services Group, Inc. NASDAQ:HCSG Details Headquarters: Bensalem, PA Website: CEO: Ted Wahl Employees: 35,300 Organization: PUB Revenues: 1,715,682,000 (2024) Net Income: 39,471,000 (2024) Release Summary HCSG Reports Second Quarter Results, Exceeds Growth Expectations, Raises 2025 Cash Flow Forecast, Announces $50.0MM Share Repurchase Plan Release Versions English Contacts Company Contacts: Theodore Wahl President and Chief Executive Officer Vikas Singh Executive Vice President and Chief Financial Officer Matthew J. McKee Chief Communications Officer 215-639-4274 investor-relations@


Business Wire
28 minutes ago
- Business Wire
CareDx to Report Second Quarter 2025 Financial Results
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the second quarter 2025 after market close on Wednesday, August 6, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing 1-800-274-8461 for domestic callers or 1-203-518-9814 for international callers. Please reference Conference ID: CareDx. To listen to the webcast, please visit the Events & Presentations section of CareDx's Investor Relations website at: About CareDx – The Transplant Company CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit:


Business Wire
28 minutes ago
- Business Wire
CDW to Announce Second Quarter 2025 Results on August 6
VERNON HILLS, Ill.--(BUSINESS WIRE)--CDW Corporation (Nasdaq: CDW) announced today that it will host a webcast conference call to discuss its second quarter 2025 results on Wednesday, August 6, 2025, at 7:30 a.m. CT/8:30 a.m. ET. A live webcast (audio with slides) of the conference call will be accessible at The press release and presentation slides will be posted on this website prior to the call. Please visit the website at least fifteen minutes prior to the call to register and to download and install any necessary software. A taped replay of the webcast will be available on the website shortly after the call. For questions, please email investorrelations@ About CDW CDW Corporation is a leading multi-brand provider of information technology solutions to business, government, education and healthcare customers in the United States, the United Kingdom and Canada. A Fortune 500 company and member of the S&P 500 Index, CDW helps its customers to navigate an increasingly complex IT market and maximize return on their technology investments. For more information about CDW, please visit CDWPR-FI